🟢 Tenax Therapeutics is trading 7.05% up in pre-market

Tenax Therapeutics is trading 7.05% up now at $1.98 after no clear company-specific catalyst was identified for August 25, 2026.

• The latest major development remains the August 10 Phase 3 LEVEL trial failure, which missed its primary endpoint.
• The August 24 after-hours move was also reported without a clear company-specific catalyst.
• Broader futures are modestly higher, but gains remain below the 0.5% threshold for a strong market explanation.